Document is current
Any future updates will be listed below
-
Authors
Ueki, Hiroshi https://orcid.org/0000-0002-6557-0771
Wang, I-Hsuan https://orcid.org/0000-0003-2159-7347
Zhao, Dongming https://orcid.org/0000-0001-7161-6214
Gunzer, Matthias https://orcid.org/0000-0002-5534-6055
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18am001007, JP19fm0108006, JP17jm0210042, JP19fk0108031, JP18am001007, JP18am001007)
Ministry of Education, Culture, Sports, Science and Technology (16H06429, 16K21723, 16H06434, 18K14580)
MEXT | Japan Society for the Promotion of Science (JP18KK0225, JP18KK0225, P16416)
the NIAID-funded Center for Research on Influenza Pathogenesis (CRIP)
- License Information
-
More Information
Article History
Received: 4 September 2019
Accepted: 3 December 2019
First Online: 29 January 2020
Competing interests
: Y.K. is a founder of FluGen and has received speaker’s honoraria from Toyama Chemical and Astellas and grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Otsuka Pharmaceutical, and Kyoritsu Seiyaku.
